Invasive pulmonary aspergillosis (IPA) remains difficult to diagnose and to treat. Most
common risk factors are prolonged neutropenia, hematopoietic stem cell or solid organ …

Invasive aspergillosis (IA) in haematology/oncology patients presents as primary infection or
breakthrough infection, which can become refractory to antifungal treatment and has a high …

Children with haematologic malignancies and haematopoietic stem cell transplant recipients
are at high risk for invasive fungal diseases (IFD). There has been an increased number of …

Antifungal prophylaxis can reduce morbidity and mortality from invasive fungal disease
(IFD). However, its use needs to be optimised and appropriately targeted to patients at …

Invasive fungal disease (IFD) due to moulds other than Aspergillus is a significant cause of
mortality in patients with malignancies or post haemopoietic stem cell transplantation. The …

Background Invasive fungal infections (IFI) are an important complication of acute
lymphoblastic leukaemia (ALL) treatment. Our study describes the prevalence and outcomes …

ABSTRACT The Practice Guidelines Committee of the American Society of Transplantation
and Cellular Therapy partnered with its Transplant Infectious Disease Special Interest Group …

Background Invasive fungal disease (IFD) is a significant complication for children receiving
treatment for leukaemia, contributing to morbidity and mortality. Recent regional paediatric …

Abstract Purpose of Review Pediatric oncology patients frequently experience episodes of
prolonged neutropenia which puts them at high risk for infection with significant morbidity …

Background Invasive fungal disease (IFD) is a common and important complication in
children with acute myeloid leukaemia (AML). We describe the epidemiology of IFD in a …